Literature DB >> 22513312

The need for translational research on drug-drug interactions.

S Hennessy1, D A Flockhart.   

Abstract

Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513312      PMCID: PMC4340251          DOI: 10.1038/clpt.2012.39

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Concordance of severity ratings provided in four drug interaction compendia.

Authors:  Jacob Abarca; Daniel C Malone; Edward P Armstrong; Amy J Grizzle; Philip D Hansten; Robin C Van Bergen; Richard B Lipton
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Mar-Apr

2.  Beyond translational research from T1 to T4: beyond “separate but equal” to integration (Ti).

Authors:  Harry P Selker
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

3.  Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

Authors:  N P Tatonetti; J C Denny; S N Murphy; G H Fernald; G Krishnan; V Castro; P Yue; P S Tsao; P S Tsau; I Kohane; D M Roden; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2011-05-25       Impact factor: 6.875

4.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

5.  Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008.

Authors:  Brian K Kit; Cynthia L Ogden; Katherine M Flegal
Journal:  Ann Epidemiol       Date:  2011-11-18       Impact factor: 3.797

6.  A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.

Authors:  J S Floyd; R Kaspera; K D Marciante; N S Weiss; S R Heckbert; T Lumley; K L Wiggins; B Tamraz; P-Y Kwok; R A Totah; B M Psaty
Journal:  Clin Pharmacol Ther       Date:  2012-03-14       Impact factor: 6.875

7.  Physician versus computer knowledge of potential drug interactions in the emergency department.

Authors:  M I Langdorf; J C Fox; R S Marwah; B J Montague; M M Hart
Journal:  Acad Emerg Med       Date:  2000-11       Impact factor: 3.451

Review 8.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

Review 9.  Epidemiology of drug-drug interactions as a cause of hospital admissions.

Authors:  C A Jankel; L K Fitterman
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

  9 in total
  11 in total

1.  Drug-drug interaction study of ACT-178882, a new renin inhibitor, and diltiazem in healthy subjects.

Authors:  Jasper Dingemanse; Laurent Nicolas
Journal:  Clin Drug Investig       Date:  2013-03       Impact factor: 2.859

Review 2.  Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.

Authors:  S Hennessy; C E Leonard; J J Gagne; J H Flory; X Han; C M Brensinger; W B Bilker
Journal:  Clin Pharmacol Ther       Date:  2015-11-23       Impact factor: 6.875

3.  Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.

Authors:  Xu Han; ChienWei Chiang; Charles E Leonard; Warren B Bilker; Colleen M Brensinger; Lang Li; Sean Hennessy
Journal:  Epidemiology       Date:  2017-05       Impact factor: 4.822

4.  Translational drug-interaction corpus.

Authors:  Shijun Zhang; Hengyi Wu; Lei Wang; Gongbo Zhang; Luis M Rocha; Hagit Shatkay; Lang Li
Journal:  Database (Oxford)       Date:  2022-05-18       Impact factor: 4.462

5.  Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.

Authors:  H Schelleman; X Han; C M Brensinger; S K Quinney; W B Bilker; D A Flockhart; L Li; Sean Hennessy
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

6.  Pharmacovigilance using clinical notes.

Authors:  P LePendu; S V Iyer; A Bauer-Mehren; R Harpaz; J M Mortensen; T Podchiyska; T A Ferris; N H Shah
Journal:  Clin Pharmacol Ther       Date:  2013-03-04       Impact factor: 6.875

Review 7.  Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics.

Authors:  Heng-Yi Wu; Aditi Shendre; Shijun Zhang; Pengyue Zhang; Lei Wang; Desta Zeruesenay; Luis M Rocha; Hagit Shatkay; Sara K Quinney; Xia Ning; Lang Li
Journal:  Clin Pharmacol Ther       Date:  2020-02-03       Impact factor: 6.875

8.  Extraction of pharmacokinetic evidence of drug-drug interactions from the literature.

Authors:  Artemy Kolchinsky; Anália Lourenço; Heng-Yi Wu; Lang Li; Luis M Rocha
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.

Authors:  X Han; S K Quinney; Z Wang; P Zhang; J Duke; Z Desta; J S Elmendorf; D A Flockhart; L Li
Journal:  Clin Pharmacol Ther       Date:  2015-09       Impact factor: 6.875

Review 10.  Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research.

Authors:  Pengyue Zhang; Heng-Yi Wu; Chien-Wei Chiang; Lei Wang; Samar Binkheder; Xueying Wang; Donglin Zeng; Sara K Quinney; Lang Li
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.